Skip to main content
. Author manuscript; available in PMC: 2016 May 1.
Published in final edited form as: Vet Ophthalmol. 2014 Jul 15;18(3):242–250. doi: 10.1111/vop.12194

Figure 2.

Figure 2

A composite phase-contrast microscopy image showing untreated control, TGFβ1-treated control, and TGFβ1 + 200 μg/ml PFD treatment groups taken 36 hours after initiation of PFD treatment. No alterations in cellular morphology were observed. Scale bar denotes 500 μm.